{
  "resourceType": "ValueSet",
  "id": "1.3.6.1.4.1.6997.4.1.2.234.999.2",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2015-08-26T01:00:02.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2",
  "version": "20150826",
  "name": "Selected urine screening for patients receiving opioid therapy",
  "status": "active",
  "date": "2015-08-26T01:00:02-04:00",
  "publisher": "ECRI Steward",
  "compose": {
    "include": [
      {
        "system": "http://loinc.org",
        "version": "2.72",
        "concept": [
          {
            "code": "19295-5",
            "display": "Opiates [Presence] in Urine by Screen method"
          },
          {
            "code": "2112-1",
            "display": "Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine"
          },
          {
            "code": "51782-1",
            "display": "Drugs of abuse 7 and Alcohol and Tricyclics panel - Urine by Screen method"
          },
          {
            "code": "65750-2",
            "display": "Drugs of abuse 5 panel - Urine by Screen method"
          }
        ]
      }
    ]
  }
}